Diosgenin Inhibits Prostate Cancer Progression by Inducing UHRF1 Protein Degradation

Rong Tang(First Affiliated Hospital of Guangdong Pharmaceutical University), Xiong Li(Central South University)
Unknown
May 12, 2022
10.22541/au.165237524.42526501/v1
Cited by 0

Related Papers

The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
|Cell Death and Disease|2017|128
PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
|Journal of Experimental & Clinical Cancer Research|2018|126